AU3107197A - Medicinal compositions for treating liver diseases - Google Patents

Medicinal compositions for treating liver diseases

Info

Publication number
AU3107197A
AU3107197A AU31071/97A AU3107197A AU3107197A AU 3107197 A AU3107197 A AU 3107197A AU 31071/97 A AU31071/97 A AU 31071/97A AU 3107197 A AU3107197 A AU 3107197A AU 3107197 A AU3107197 A AU 3107197A
Authority
AU
Australia
Prior art keywords
liver diseases
medicinal compositions
treating liver
medicinal
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31071/97A
Inventor
Masato Higuchi
Junji Kato
Yoshiro Niitsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU3107197A publication Critical patent/AU3107197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU31071/97A 1996-06-20 1997-06-13 Medicinal compositions for treating liver diseases Abandoned AU3107197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-160320 1996-06-20
JP16032096 1996-06-20
PCT/JP1997/002054 WO1997048411A1 (en) 1996-06-20 1997-06-13 Medicinal compositions for treating liver diseases

Publications (1)

Publication Number Publication Date
AU3107197A true AU3107197A (en) 1998-01-07

Family

ID=15712416

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31071/97A Abandoned AU3107197A (en) 1996-06-20 1997-06-13 Medicinal compositions for treating liver diseases

Country Status (5)

Country Link
US (1) US6268336B1 (en)
EP (2) EP0938901A4 (en)
AU (1) AU3107197A (en)
TW (1) TW586933B (en)
WO (1) WO1997048411A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR019025A1 (en) 1998-04-09 2001-12-26 Roche Diagnostics Gmbh USE OF ERYTHROPOYETIN IN LOW DOSE TO PRODUCE A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HEMOCROMATOSIS, COMBINED PHARMACEUTICAL PREPARATION USED ACCORDING TO SUCH USE AND PHARMACEUTICAL UNIT PACKAGING CONTAINING THE PHARMACEUTICAL COMBINED PREPARED REFERENCE
EP0965349A1 (en) * 1998-06-18 1999-12-22 Roche Diagnostics GmbH Use of erythropoietin for the treatment of hemochromatosis
HUP0201068A3 (en) 1999-04-09 2002-10-28 Ortho Mcneil Pharm Inc Pharmaceutical compositions of erythropoietin
CA2407785A1 (en) * 2000-05-02 2001-11-08 Action Pharma Aps Use of .alpha.-msh and epo for preventing or treating ischemic conditions
DE60140054D1 (en) 2000-06-30 2009-11-12 Tokyo Metropolitan Inst Of Ger PREVENTIVA AND THERAPEUTICS FOR DEMYELINISATION ASSOCIATED DISEASES
MXPA03001039A (en) * 2000-08-02 2004-09-10 Johnson & Johnson Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin.
US6495170B1 (en) * 2000-08-16 2002-12-17 N. V. Nutricia Method of increasing the presence of glutathione in cells
US6833351B2 (en) * 2001-05-21 2004-12-21 Douglas T. Dieterich Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
WO2004023145A1 (en) 2002-09-04 2004-03-18 Perseus Proteomics Inc. Method of diagnosing cancer by detecting gpc3
WO2005070451A1 (en) * 2004-01-22 2005-08-04 Zafena Aktiebolag Pharmaceutical composition comprising non-glycosylated erythropoietin
US7686775B2 (en) * 2004-04-09 2010-03-30 Branch Thomas P Method and apparatus for multidirectional positioning of a shoulder
US7588745B2 (en) * 2004-04-13 2009-09-15 Si Options, Llc Silicon-containing products
AR053416A1 (en) 2005-11-10 2007-05-09 Protech Pharma S A COMBINATION OF GLICOISOFORMS FOR THE TREATMENT OR PREVENTION OF SEPTICEMIA, TRANSGENIC CELLULAR LINE PRODUCING ERYTHROPOYETINE GLICOFORMES, PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMBINATION, PROCEDURES TO OBTAIN THE CELLULAR PROCEDURE
JP4248544B2 (en) * 2005-12-19 2009-04-02 株式会社椿本チエイン Movable guide for transmission
NZ602170A (en) 2008-02-08 2014-03-28 Ambrx Inc Modified leptin polypeptides and their uses
JP5680534B2 (en) 2008-07-23 2015-03-04 イーライ リリー アンド カンパニー Modified bovine G-CSF polypeptides and their use
MX2011003272A (en) 2008-09-26 2011-04-28 Ambrx Inc Modified animal erythropoietin polypeptides and their uses.
TWI480288B (en) 2010-09-23 2015-04-11 Lilly Co Eli Formulations for bovine granulocyte colony stimulating factor and variants thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013718A (en) 1986-11-21 1991-05-07 Amgen, Inc. Method for treating iron overload using EPO
JPS6444317A (en) 1987-08-12 1989-02-16 Diesel Kiki Co Vehicle heating device
JPH062070B2 (en) 1988-07-06 1994-01-12 農林水産省食品総合研究所長 ▲ O --- Method for producing acylamino acid
EP0450713A1 (en) * 1990-03-30 1991-10-09 Rjr Polymers Inc Iso-thermal seal process for electronic devices

Also Published As

Publication number Publication date
WO1997048411A1 (en) 1997-12-24
US6268336B1 (en) 2001-07-31
TW586933B (en) 2004-05-11
EP1634604A1 (en) 2006-03-15
EP0938901A4 (en) 2001-10-31
EP0938901A1 (en) 1999-09-01

Similar Documents

Publication Publication Date Title
AU6513298A (en) Therapeutic compositions
AU1875997A (en) Pharmaceutical composition for immunomodulation
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU4762797A (en) Pharmaceutical compositions
AU5136998A (en) Medicinal composition
AU4067697A (en) Therapeutic compositions for treatment of cancer
AU2967597A (en) Pharmaceutical compositions
AU2027695A (en) Pharmaceutical composition for treating stoma-peripheral inflammation diseases
AU3107197A (en) Medicinal compositions for treating liver diseases
AU3777897A (en) Pharmaceutical compositions
AU2027495A (en) Pharmaceutical composition for treating hemorrhoidal diseases
AU2531295A (en) Pharmaceutical composition
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
AU3460897A (en) Medicinal compositions
ZA977874B (en) Pharmaceutical compositions for treating viral diseases
AUPN727595A0 (en) Therapeutic compositions
AU4326197A (en) Pharmaceutical compositions
AUPN862596A0 (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AU2961699A (en) Medicinal compositions for treating edema
AU1427895A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
AU7641098A (en) Therapeutic composition
AU7190496A (en) Therapeutic compositions